Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Fluorescein vs Phenazopyridine for Ureteral Patency
NCT02757417Withdrawn
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jul 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of fluorescein in ureteral injury (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Differences in time that elapses between starting cystoscopy and identifying both ureteral jets. Planned start Jul 2016; status: withdrawn.
02
Drugs
fluorescein
03
Conditions
ureteral injury
Beyond the preview
Go deeper on NCT02757417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02757417.